Mixed phenotype cardiomyopathy, associated with DSP genetic variant: a case report and literature review.

We report a case of mixed phenotype cardiomyopathy (non-compaction cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy), associated with DSP genetic variant.  The sudden cardiac death was the first and only symptom.

1. Berger S, Utech L, Fran Hazinski M. Sudden death in children and adolescents. Pediatric Clinics of North America. 2004;51(6 SPEC. ISS.):1653–77. doi:10.1016/j.pcl.2004.07.004.

2. Shlyakhto EV, Arutiunov GP, Belenkov IUN et al. National guidelines for the risk stratification and the prevention of sudden cardiac death (second edition). M.: ID "Medpraktika-M"; 2018 p. 247. (In Russ.)

3. Kaltman JR, Thompson PD, Lantos J et al. Screening for sudden cardiac death in the young: Report from a national heart, lung, and blood institute working group. Circulation. 2011;123(17):1911–8. doi:10.1161/CIRCULATIONAHA.110.017228.

4. Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16. doi:10.1161/CIRCULATIONAHA.106.174287.

5. Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6. doi:10.1093/eurheartj/ehm342.

6. Towbin JA, McKenna WJ, Abrams DJ et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019;16(11):e301–72. doi:10.1016/j.hrthm.2019.05.007.

7. Corrado D, Wichter T, Link MS et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement. Eur Heart J. 2015;36(46):3227–37. doi:10.1093/eurheartj/ehv162.

8. Smith W, Members of CSANZ Cardiovascular Genetics Working G. Guidelines for the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy. Hear Lung Circ. 2011;20(12):757–60. doi:10.1016/j.hlc.2011.07.019.

9. Kapplinger JD, Landstrom AP, Salisbury BA et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia- associated mutations from background genetic noise. J Am Coll Cardiol. 2011;57(23):2317–27. doi:10.1016/j.jacc.2010.12.036.

10. Lombardi R, Marian AJ. Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: A disease of cardiac stem cells. Pediatr Cardiol. 2011;32(3):360–5. doi:10.1007/s00246-011-9890-2.

11. Lutokhina Yu..A., Blagova О.V., Nedostup A.V. et al. Clinical types (classification) of the right ventricle arrhythmogenic dysplasia: specifics of diagnostics and management. Russ J Cardiol. 2018;(2):19-31. (In Russ.). doi:10.15829/1560-4071-2018-2-19-31.

12. Thiene G, Nava A, Corrado D et al. Right Ventricular Cardiomyopathy and Sudden Death in Young People. N Engl J Med. 1988;318(3):129–33. doi:10.1056/NEJM198801213180301.

13. Gordeeva MV, Mitrofanova LB, Pakhomov AV et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia as a cause of sudden cardiac death of young adults. J Arrhythmology. 2012;(69):38–48. (In Russ.).

14. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: Clinical forms and main differential diagnoses. Circulation. 1998;97(16):1532–5. doi:10.1161/01.CIR.97.16.1532.

15. Fontaine G, Brestescher C, Fontaliran F et al. Outcome of arrhythmogenic right ventricular dysplasia. Apropos of 4 cases. Arch Mal Coeur Vaiss. 1995;88(7):973–9. PMID: 7487328. Accessed 24 Aug 2020.

16. Arbustini E, Narula N, Dec GW et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the world heart federation. J Am Coll Cardiol. 2013;62(22):2046–72. doi:10.1016/j.jacc.2013.08.1644.

17. Aras D, Ozeke O, Cay S et al. Arrhythmogenic noncompaction cardiomyopathy: Is there an echocardiographic phenotypic overlap of two distinct cardiomyopathies? J Cardiovasc Ultrasound. 2015;23(3):186–90. doi:10.4250/jcu.2015.23.3.186.

18. Poliakova A., Krutikov A., Semernin E., Kostareva A., Gudkova A. The clinical use of the MOGE(S) classification in the differential diagnosis between idiopathic hypertrophic cardiomyopathy and its phenocopies. Russian Journal of Cardiology. 2019;24(11):35-41. (In Russ.). doi: 10.15829/1560-4071-2019-11-35-41.

19. Melnik OV, Gudkova AY, Vershinina TL et al. Clinical polymorphism of RASopathies in terms of the children's cardiology department. Cons Medicum. 2017;19(12):100–4. (In Russ.). doi:10.26442/2075-1753_19.12.100-104.

20. Miszalski-Jamka K, Jefferies JL, Mazur W et al. Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients with Left Ventricular Noncompaction. Circ Cardiovasc Genet. 2017;10(4):e001763. doi:10.1161/CIRCGENETICS.117.001763.

21. Vaikhanskaya TG, Sivitskaya LN, Kurushko TV et al. Left ventricular noncompaction: a distinct cardiomyopathy or a composite anatomical syndrome? Kardiologiia. 2018;58(11S):33-45. (In Russ.).doi: 10.18087/cardio.2558.

22. Galaktionov AA. Troponin: reference range for blood tests, kinds of tests, causes of its elevation in myocardial infarction. (In Russ.) Галактионов А.А. Тропонин: норма в крови, виды тестов, причины повышения при инфаркте. https://cardiogid.com/troponin/. (24 Aug 2020).

23. Pacheco Claudio C, Quesada O, Pepine CJ et al. Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease). Clin Cardiol. 2018;41(2):185–93. doi:10.1002/clc.22894.

24. Averkov OV, Barbarash OL, Boytsov SA et al. Differentiated approach in diagnostics, diagnosis formulation, case management and statistical accounting of type 2 myocardial infarction (Position Paper). Russ J Cardiol. 2019;(6):7-21. (In Russ.). doi: 10.15829/1560-4071-2019-6-7-21.

25. Scalone G, Niccoli G, Crea F. Editor’s Choice- Pathophysiology, diagnosis and management of MINOCA: an update. Eur Hear journal Acute Cardiovasc care. 2019;8(1):54–62. doi: 10.1177/2048872618782414.

26. Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi: 10.1038/gim.2015.30.

27. Udeoji DU, Philip KJ, Morrissey RP et al. Left ventricular noncompaction cardiomyopathy: Updated review. Ther Adv Cardiovasc Dis. 2013;7(5):260–73. doi:10.1177/1753944713504639.

28. Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41. doi:10.1161/CIRCULATIONAHA.108.840827.

29. Mavrogeni SI, Bacopoulou F, Apostolaki D et al. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance. Eur J Clin Invest. 2018;48(7):e12955. doi:10.1111/eci.12955.

30. Miyake CY, Kim JJ. Arrhythmias in Left Ventricular Noncompaction. Cardiac Electrophysiology Clinics. 2015;7(2):319–30. doi:10.1016/j.ccep.2015.03.007.

31. Caliskan K, Ujvari B, Bauernfeind T et al. The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias. J Cardiovasc Electrophysiol. 2012;23(9):938–44. doi:10.1111/j.1540-8167.2012.02325.x.

32. Zhou H, Lin X, Fang L et al. Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction. Int J Cardiovasc Imaging. 2017;33(12):2013–20. doi:10.1007/s10554-017-1209-9.

33. Lahmiti S, Aboussad A. Isolated non-compaction of the right ventricular myocardium: two cases report. Ann Cardiol d’Angeiol. 2012;61(4):299–302.doi: 10.1016/j.ancard.2010.12.001.

34. Stöllberger C, Gerecke B, Finsterer J, Engberding R. Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol. 2013;165(3):463–7. doi:10.1016/j.ijcard.2011.08.845.

35. Ichida F, Hamamichi Y, Miyawaki T et al. Clinical features of isolated noncompaction of the ventricular myocardium: Long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol. 1999;34(1):233–40. doi:10.1016/S0735-1097(99)00170-9.

36. Nugent AW, Daubeney PEF, Chondros P et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–46. doi: 10.1056/NEJMoa021737.

37. Lilje C, Rázek V, Joyce JJ et al. Complications of non-compaction of the left ventricular myocardium in a paediatric population: A prospective study. Eur Heart J. 2006;27(15):1855–60. doi:10.1093/eurheartj/ehl112.

38. Paterick TE, Jamil Tajik A. Left ventricular noncompaction: - A diagnostically challenging cardiomyopathy. Circulation Journal. 2012;76(7):1556–62. doi:10.1253/circj.CJ-12-0666.

39. Pugliatti P, Di Bella G, Recupero A et al. Non compaction cardiomyopathy and Antiphospholipid syndrome: A catastrophic thromboembolic association. Int J Cardiol. 2008;128(1):126–8. doi:10.1016/j.ijcard.2007.05.043.

40. Tenedios F, Erkan D, Lockshin MD. Cardiac Manifestations in the Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America. 2006;32(3):491–507. doi:10.1016/j.rdc.2006.05.008.

41. Gabrielli FA, Lombardo A, Natale L et al. Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI. Int J Cardiol. 2006;111(2):315–7. doi:10.1016/j.ijcard.2005.09.054.

42. Swinkels BM, Boersma LVA, Rensing BJ et al. Isolated left ventricular noncompaction in a patient presenting with a subacute myocardial infarction. Netherlands Hear J. 2007;15(3):109–11. doi:10.1007/BF03085964.

43. Correia AF, Oliveira DC, Sanctos M. Coronary Artery Thromboses, Stent Thrombosis and Antiphospholipid Antibody Syndrome: Case Report. Cardiol Res. 2018;9(2):129–32.

44. Toufan M, Shahvalizadeh R, Khalili M. Myocardial infarction in a patient with left ventricular noncompaction: A case report. Int J Gen Med. 2012;(5):661–5. doi:10.2147/IJGM.S28902.

45. Fettouhi H, Tamdy A, Ellouali F et al. Convulsives crisis revealing left-ventricular non-compaction with apical myocardial infarction. Ann Cardiol Angeiol. 2011;60(3):159–64. doi:10.1016/j.ancard.2010.12.008.

46. Güvenç TS, Erer HB, Altay S et al. “Idiopathic” acute myocardial infarction in a young patient with noncompaction cardiomyopathy. Cardiol J. 2012;19(4):429–33. doi:10.5603/CJ.2012.0077.

47. Pulignano G, Tinti MD, Tolone S et al. Noncompaction and embolic myocardial infarction: The importance of oral anticoagulation. Rev Port Cardiol. 2015;34(7-8):497.e1-497.e4. doi:10.1016/j.repc.2015.01.014.

48. Panduranga P, Mukhaini MK. Left-ventricular non-compaction with coronary artery disease. Int J Cardiol. 2011;150(1):e37-e39. doi:10.1016/j.ijcard.2009.09.476.

49. Martherus R, Jain R, Takagi K et al. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed wnt/β-catenin signaling. Am J Physiol - Hear Circ Physiol. 2016;310(2):H174–87. doi:10.1152/ajpheart.00295.2015.

50. Arbustini E, Favalli V, Narula N et al. Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy? Journal of the American College of Cardiology. 2016;68(9):949–66. doi: 10.1016/j.jacc.2016.05.096.

51. Williams T, Machann W, Kühler L et al. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma. Clin Res Cardiol. 2011;100(12):1087–93. doi:10.1007/s00392-011-0345-9.

52. Tufekcioglu O, Aras D, Sahin O et al. Two cardiomyopathies in one heart. Echocardiography. 2006;23(6):519–21. doi:10.1111/j.1540-8175.2006.00253.x.

53. Wlodarska EK, Wozniak O, Konka M et al. Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy - A study of nine patients. Int J Cardiol. 2010;145(1):107–11. doi:10.1016/j.ijcard.2009.05.062.

54. Streltsova AA, Gudkova AY, Kostareva AA. Left ventricular non - compaction: contemporary view of genetic background, clinical course, diagnostic and treatment.Terapevticheskii Arkhiv. 2019; 91(12):90-7. (In Russ.).doi:10.26442/00403660.2019.12.000142.

55. Li S, Zhang C, Liu N et al. Genotype-positive status is associated with poor prognoses in patients with left ventricular noncompaction cardiomyopathy. J Am Heart Assoc. 2018;7(20):e009910. doi:10.1161/JAHA.118.009910.

56. Towbin JA. Inherited cardiomyopathies. Circulation Journal. 2014;78(10):2347–56. doi: 10.1253/circj.CJ-14-0893.

57. Herren T, Gerber PA, Duru F. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: A not so rare “disease of the desmosome” with multiple clinical presentations. Clinical Research in Cardiology. 2009;98(3):141–58. doi: 10.1007/s00392-009-0751-4.

58. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-Dominant Arrhythmogenic Cardiomyopathy. An Under-Recognized Clinical Entity. J Am Coll Cardiol. 2008;52(25):2175–87. doi:10.1016/j.jacc.2008.09.019.